This article is more than 5 years old. Information may no longer be current.

Foundation names award recipients

Issue: January 25, 2013

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ASCO’s Conquer Cancer Foundation has announced the 25 recipients of its 2013 Merit Awards in Gastrointestinal Cancers.

The awards are designed to promote clinical research by young oncology scientists. Recipients will have the opportunity to present their research and interact with other clinical investigators at the 2013 Gastrointestinal Cancers Symposium, scheduled for Jan. 24-26 in San Francisco.

"The Conquer Cancer Foundation is pleased to recognize the 2013 Merit Award recipients for their dedication to conducting essential gastrointestinal cancer research," Martin J. Murphy, DMedSc, PhD, chair of the foundation’s board of directors, said in a press release. "The work of these researchers is vital for patients living with cancer as it improves the care that they receive and makes it possible for them to spend more time with the people they love."

Recipients of awards for research in colorectal cancer are:

• Chiara Cremolini, MD, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori;
• Aalok Kumar, B.ESc., MD, British Columbia Cancer Agency;
• Van Morris, MD, The University of Texas MD Anderson Cancer Center; and
• Andrea Russo, MD, Harvard Radiation Oncology Program.

Additional award recipients are:

• Sarah Barton, MBChB, FRACP, Auckland District Health Board;
• Seth Bellister, MD, The University of Texas MD Anderson Cancer Center;
• Young Chae, MD, MPH, MBA, The University of Texas MD Anderson Cancer Center;
• Michael Chuong, MD, H. Lee Moffitt Cancer Center and Research Institute;
• Alexandra Drakaki, MD, Beth Israel Deaconess Medical Center;
• Luca Faloppi, MD, Scuola di Specializzazione in Oncologia Medica, Università Politecnica delle Marche;
• Olusola Faluyi, MRCP, PhD, Princess Margaret Hospital;
• Jessica Freilich, MD, H. Lee Moffitt Cancer Center and Research Institute;
• Jordan Kharofa, MD, Medical College of Wisconsin;
• Nishi Kothari, MD, H. Lee Moffitt Cancer Center & Research Institute;
• David Luyimbazi, MD, City of Hope Medical Center;
• Ludmila Martin, MD, The Ohio State University Medical Center;
• Florencia McAllister, MD, The Johns Hopkins University;
• Gerald Prager, MD, Medical University of Vienna;
• Vaibhav Sahai, MD, MS, Northwestern University Feinberg School of Medicine;
• Vikas Sehdev, PhD, Vanderbilt University;
• John Shen, MD, Moores Cancer Center;
• Kazuki Sudo, MD, The University of Texas MD Anderson Cancer Center;
• Elizabeth Won, MD, Memorial Sloan-Kettering Cancer Center;
• Joyce Wong, MD, H. Lee Moffitt Cancer Center and Research Institute; and
• Changho Yoo, MD, Asan Medical Center, University of Ulsan College of Medicine.